Research Funded by Box Rallies

Featured Research

Dr Pidsley and her team's research will lead to the development of a novel sensitive epigenetic test to more accurately determine tumour risk, particularly for tumours that are inaccurately classified using current clinical tools.

Explore Research

Developing Better Targeted Treatments for Adults with Hard-to-Treat Blood Cancer (B -ALL)

VIC

Developing inhibitors of the LMO4 oncoprotein

NSW

Developing less toxic treatment approaches for childhood brain cancer

Dual targeting of oncogenic cofactors MYC and histone deacetylase in high-risk childhood brain tumours

NSW

EAGLE FM Study: EvaluAtion of Groin Lymphadenectomy Extent For metastatic Melanoma

NSW

Effects of increased colonic butyrate on inherited colon cancer

VIC

Engineering childhood cancer for precision medicine

NSW

Evaluating new immunotherapies targeting the FAT1 cadherin in high risk leukaemia

NSW

Exploiting a new epigenetic regulatory mechanism for sustaining leukaemia-initiating activity

NSW

Finding new treatment targets for advanced melanoma

QLD

Finding new ways to treat liver cancer

Functional characterisation of the putative tumour suppressor gene MCC in colorectal cancer

NSW

Gene modified T cells expressing a chimeric antigen receptor for a kappa light chain antigen to treat multiple myeloma

NSW

Harnessing androgen-mediated viral mimicry to improve immunotherapy in prostate cancer

HCC Outcomes mitigation and disease Prevention through Clinical Partnerships (HOPE)

NSW

Ibudilast as a treatment for chemotherapy-induced peripheral neuropathies and cognitive impairments

NSW

Identification and targeting of a new subtype of estrogen receptor breast positive breast cancer

Identifying the drivers of stomach cancer to find more effective treatments

VIC